Abstract:Anticancer drugs induce apoptotic and non-apoptotic cell death in various cancer types. The signaling pathways for anticancer drug-induced apoptotic cell death have been shown to differ between drug-sensitive and drug-resistant cells. In atypical multidrug-resistant leukemia cells, the c-Jun/activator protein 1 (AP-1)/p53 signaling pathway leading to apoptotic death is altered. Cancer cells treated with anticancer drugs undergo c-Jun/AP-1–mediated apoptotic death and are involved in c-Jun N-terminal kinase activation and growth arrest- and DNA damage-inducible gene 153 (Gadd153)/CCAAT/enhancer-binding protein homologous protein pathway induction, regardless of the p53 genotype. Gadd153 induction is associated with mitochondrial membrane permeabilization after anticancer drug treatment and involves a coupled endoplasmic reticulum stress response. The induction of apoptosis by anticancer drugs is mediated by the intrinsic pathway (cytochrome c, Cyt c) and subsequent activation of the caspase cascade via proapoptotic genes (e.g., Bax and Bcl-xS) and their interactions. Anticancer drug-induced apoptosis involves caspase-dependent and caspase-independent pathways and occurs via intrinsic and extrinsic pathways. The targeting of antiapoptotic genes such as Bcl-2 enhances anticancer drug efficacy. The modulation of apoptotic signaling by Bcl-xS transduction increases the sensitivity of multidrug resistance-related protein-overexpressing epidermoid carcinoma cells to anticancer drugs. The significance of autophagy in cancer therapy remains to be elucidated. In this review, we summarize current knowledge of cancer cell death-related signaling pathways and their alterations during anticancer drug treatment and discuss potential strategies to enhance treatment efficacy.

Targeting apoptosis in cancer therapy

Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells.

Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review

Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics

Anti-Apoptotic Mechanisms of Drug Resistance in Cancer

Cell death pathologies: targeting death pathways and the immune system for cancer therapy

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.

Modulation of apoptosis signaling pathways and cell cycle regulation.

Cell death pathways: molecular mechanisms and therapeutic targets for cancer

Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy

Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies

Targeting Apoptotic Pathway of Cancer Cells with Phytochemicals and Plant-Based Nanomaterials

Apoptosis: A Target for Anticancer Therapy

Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy

Small molecules targeting tumor apoptosis related proteins and genes

Targeting Programmed Cell Death Using Small-Molecule Compounds To Improve Potential Cancer Therapy

Targeting Apoptosis in AML: Where Do We Stand?

Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance

Targeting Apoptotic and Autophagic Pathways for Cancer Therapeutics

Apoptosis: A Comprehensive Overview of Signaling Pathways, Morphological Changes, and Physiological Significance and Therapeutic Implications

Targeting Programmed Cell Death Using Small‐Molecule Compounds to Improve Potential Cancer Therapy